Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma

This publication has 17 references indexed in Scilit:

• Initial Experience with the Radiotracer Anti-1-amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid (Anti-[18F]FACBC) with PET in Renal Carcinoma
  Molecular Imaging and Biology, 2009
• Significance of ¹⁸ F‐fluorodeoxyglucose positron‐emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma
  BJU International, 2009
• ¹⁸ F-FDG PET/CT Imaging for an Early Assessment of Response to Sunitinib in Metastatic Renal Carcinoma: Preliminary Study
  Cancer Biotherapy and Radiopharmaceuticals, 2009
• Positron Emission Tomography Enhancing Tumor Thrombus in Patient With Renal Cell Carcinoma
  Urology, 2009
• Whole-Body F-18 Sodium Fluoride PET-CT in a Patient With Renal Cell Carcinoma
  Clinical Nuclear Medicine, 2008
• Molecular Positron Emission Tomography and PET/CT Imaging in Urological Malignancies
  European Urology, 2007
• Meta-análisis sobre el rendimiento diagnóstico de la tomografía por emisión de positrones con 18F-FDG en el carcinoma de células renales
  Revista Española de Medicina Nuclear, 2007
• Fluorine-18 Fluorothymidine: A New Positron Emission Radioisotope for Renal Tumors
  Clinical Nuclear Medicine, 2006
• Sarcomatoid renal cell carcinoma: Rapid dissemination detected on FDG PET‐CT
  Australasian Radiology, 2006
• Assessing regional hypoxia in human renal tumours using ¹⁸ F‐fluoromisonidazole positron emission tomography
  BJU International, 2005